2-hydroxyalantolactone has been researched along with Leucocythaemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dawood, M; Efferth, T; Elbadawi, M; Hegazy, MF; Klauck, SM; Mahmoud, N; Mohamed, N; Sugimoto, Y | 1 |
1 other study(ies) available for 2-hydroxyalantolactone and Leucocythaemia
Article | Year |
---|---|
2α-Hydroxyalantolactone from Pulicaria undulata: activity against multidrug-resistant tumor cells and modes of action.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pulicaria; Sesquiterpenes | 2021 |